almost
individu
merscov
infect
fever
main
symptom
admiss
howev
occurr
fever
surpris
mostli
selfreport
patient
studi
clinic
featur
sar
except
equival
select
bias
note
furthermor
similar
sar
peopl
mer
upperrespiratorytract
symptom
sore
throat
rhinorrhoea
provid
mean
discrimin
mer
common
cold
adult
strike
diff
erenc
sar
high
rate
underli
comorbid
patient
mer
viru
yet
fulli
adapt
human
infect
might
like
caus
ill
peopl
weaken
preexist
diseas
howev
caution
necessari
interpret
comorbid
data
compar
rate
aff
ect
patient
expos
popul
studi
adult
attend
outpati
depart
riyadh
diabet
overal
includ
older
year
assiri
colleagu
report
patient
older
year
diabet
preval
seem
high
view
background
rate
furthermor
half
patient
includ
outbreak
centr
around
haemodialysi
unit
rate
chronic
kidney
diseas
hypertens
note
would
therefor
expect
overal
context
sinc
communitybas
studi
unavail
comparison
reason
regard
mer
diseas
restrict
peopl
underli
disord
unfortun
fi
nding
assiri
colleagu
studi
rapid
progress
respiratori
failur
intub
individu
mer
occur
week
onset
symptom
day
earlier
sar
fi
nding
accord
high
rate
haemoptysi
seen
patient
mer
suggest
sever
lung
injuri
data
preliminari
infect
studi
lung
explant
inde
indic
merscov
reach
higher
replic
level
show
broader
cell
tropism
lower
human
respiratori
tract
sarscov
even
capillari
endotheli
cell
lung
becam
infect
postmortem
analys
experiment
studi
need
understand
merscov
induc
lung
failur
rapidli
sever
use
recommend
realtim
rtpcr
assay
assiri
colleagu
studi
mean
compar
virolog
featur
merscov
infect
cohort
situat
much
diff
erent
sar
experi
divers
homebrew
rtpcr
formul
made
crossstudi
comparison
diffi
cult
key
question
whether
use
upperrespiratorytract
sampl
rtpcrbase
diagnost
basi
experi
would
judg
eight
upperrespiratorytract
sampl
obtain
assiri
colleagu
studi
diffi
cult
interpret
name
cycl
threshold
ct
valu
greater
ct
technic
surrog
viral
load
higher
number
indic
lower
viral
load
rate
better
note
patient
sar
third
laboratoryconfi
rmed
case
yield
viru
upperrespiratorytract
sampl
valu
report
assiri
colleagu
also
show
viral
load
upper
respiratori
tract
higher
patient
mer
treat
oversea
thu
investig
later
diseas
cours
note
seven
upperrespiratorytract
swab
ct
estim
viral
load
could
exceed
fi
million
viral
genom
copi
per
sampl
impli
effi
cient
viral
shed
upper
respiratori
tract
patient
assum
mathemat
project
mer
epidem
ascertain
relev
data
mer
epidemiolog
need
develop
serolog
assay
use
sampl
well
defi
ned
group
patient
describ
populationbas
antibodi
test
could
establish
extent
merscov
infect
instead
see
tip
iceberg
repres
case
admit
summaris
import
paper
institut
virolog
univers
bonn
medic
centr
bonn
germani
drosten
virologybonnd
declar
confl
ict
interest
lancet
infecti
diseas
catherin
ison
colleagu
describ
recent
dissemin
pena
mosaic
gene
neisseria
gonorrhoea
england
wale
particularli
among
men
sex
men
fi
nding
indic
creep
resist
cefi
ximeth
former
fi
rstline
treatment
gonorrhoeaand
much
slower
develop
ceftriaxon
resist
breakpoint
mgl
decreas
suscept
report
previous
usa
typic
men
sex
men
similar
relat
mosaic
pena
resist
gene
isol
case
resist
drug
also
record
franc
spain
japan
although
cefi
xime
use
standard
treatment
mid
sporad
case
resist
note
man
howev
gener
preval
ceftriaxon
